
PHREESIA INC
PHRNYSETrading Snapshot
- Day Range
- $12.18 โ $12.49
- 52-Week Range
- $7.77 โ $32.76
- Volume
- $1.64B
- Avg Volume
- $1.88B
- Shares Outstanding
- 61.8M
- Next Earnings
- Oct 14, 2026
Fundamentals Snapshot
- Annual Revenue
- $481M
- Last Q Revenue
- $131M
- P/E Ratio
- 83.3
- P/S Ratio
- 1.5x
- EPS (TTM)
- $0.15
- Dividend Yield
- โ
Why Investors Own PHR
- โHigh-growth profile โ revenue up +36.2% YoY with expanding US Equity exposure.
- โHealthy economics โ 63% gross margin and 7% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About PHREESIA INC
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates

Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
ALL-REMOTE COMPANY/WILMINGTON, Del., August 06, 2026--Phreesia will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026.

Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates
Enovis (ENOV) delivered earnings and revenue surprises of +8.43% and +0.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of +113.33% and +15.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies
ALL-REMOTE COMPANY/WILMINGTON, Del., July 23, 2026--Phreesia and March of Dimes announce a partnership to enhance critical physician-patient conversations during prenatal and postpartum appointments.

Should Value Investors Buy Phreesia (PHR) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider
ALL-REMOTE COMPANY/WILMINGTON, Del., July 21, 2026--MediFind, a data-powered online provider directory offered by Phreesia, is announcing the launch of Chloe, its new "Find the Right Provider" chatbot.